Renal cell carcinoma (RCC) accounted for 2.2% of new cancer diagnoses worldwide in
2018 with over 400,000 new cases and 175,098 deaths [1]. The majority of RCCs are …

Renal cell carcinoma (RCC) is a malignant tumor and the third most common urinary
disease. It was estimated that RCC affected over 350,000 individuals in 2013, and there are …

Urologists play a pivotal role in many aspects of the care of patients with renal cell
carcinoma (RCC). However, until recently, in some European countries, they have rarely …

肿瘤分子病理学的不断发展对肾细胞癌的分类和诊疗方案产生重大影响, 这也促使病理诊断工作
者紧跟时代的步伐, 不断更新相关知识和理念. 为此中华医学会病理学分会泌尿与男性生殖学组 …

In this article, we report the breakthrough acquisitions for renal cell carcinoma (RCC)
management presented at the 2024 American Society of Clinical Oncology (ASCO) …

Kidney cancer represents about 5% of all new cancer diagnoses. The most common form of
kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC). This entity …

Renal cell carcinomas (RCC) are emerging as a complex set of diseases that are having a
major socioeconomic impact and showing a continued rise in incidence throughout the …